These include the Cobas EGFR mutation test V2, which can identify EGFR mutations in non-small cell lung cancer, and the Therascreen PIK3CA RGQ PCR kit, which can identify PIK3CA mutations in breast cancer [170]. This evidence concerns the gene PIK3CA and breast carcinoma.